Display options
Cite
Ananworanich J, Kosalaraksa P, Siangphoe U, et al. A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS Res Ther. 2008;5:24doi: 10.1186/1742-6405-5-24.
Ananworanich, J., Kosalaraksa, P., Siangphoe, U., Engchanil, C., Pancharoen, C., Lumbiganon, P., Intasan, J., Apateerapong, W., Chuenyam, T., Ubolyam, S., Bunupuradah, T., Lange, J., Cooper, D. A., Phanuphak, P. (2008). A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS research and therapy, 524. https://doi.org/10.1186/1742-6405-5-24
Ananworanich, Jintanat, et al. "A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection." AIDS research and therapy vol. 5 (2008): 24. doi: https://doi.org/10.1186/1742-6405-5-24
Ananworanich J, Kosalaraksa P, Siangphoe U, Engchanil C, Pancharoen C, Lumbiganon P, Intasan J, Apateerapong W, Chuenyam T, Ubolyam S, Bunupuradah T, Lange J, Cooper DA, Phanuphak P. A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS Res Ther. 2008 Oct 28;5:24. doi: 10.1186/1742-6405-5-24. PMID: 18957095; PMCID: PMC2584102.
Copy Download .nbib Format: NLM
Share it on

AIDS Res Ther. 2008 Oct 28;5:24. doi: 10.1186/1742-6405-5-24.

A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection.

AIDS research and therapy

Jintanat Ananworanich, Pope Kosalaraksa, Umaporn Siangphoe, Chulapan Engchanil, Chitsanu Pancharoen, Pagakrong Lumbiganon, Jintana Intasan, Wichitra Apateerapong, Theshinee Chuenyam, Sasiwimol Ubolyam, Torsak Bunupuradah, Joep Lange, David A Cooper, Praphan Phanuphak,

Affiliations

  1. HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Thai Red Cross AIDS Research Center, Bangkok, Thailand. [email protected]

PMID: 18957095 PMCID: PMC2584102 DOI: 10.1186/1742-6405-5-24

Abstract

OBJECTIVE: To evaluate the feasibility of a large immediate versus deferred antiretroviral therapy (ART) study in children.

METHODS: We conducted an open-label pilot randomized clinical trial study in 43 Thai children with CD4 15 to 24% of starting generic AZT/3TC/NVP immediately (Arm 1) or deferring until CD4 < 15% or CDC C (Arm 2). Primary endpoints were recruitment rate, adherence to randomized treatment and retention in trial. Secondary endpoints were % with CDC C or CD4 < 15%. Children were in the trial until the last child reached 108 weeks. Intention to treat and on treatment analyses were performed.

RESULTS: Recruitment took 15 months. Twenty-six of 69 (37.7%) were not eligible due mainly to low CD4%. Twenty four and 19 were randomized to arms 1 and 2 respectively. All accepted the randomized arm; however, 3 in arm 1 stopped ART and 1 in arm 2 refused to start ART. Ten/19 (53%) in arm 2 started ART. At baseline, median age was 4.8 yrs, CDC A:B were 36:7, median CD4 was 19% and viral load was 4.8 log. All in arm 1 and 17/19 in arm 2 completed the study (median of 134 weeks). No one had AIDS or death. Four in immediate arm had tuberculosis. Once started on ART, deferred arm children achieved similar CD4 and viral load response as the immediate arm. Adverse events were similar between arms. The deferred arm had a 26% ART saving.

CONCLUSION: Almost 40% of children were not eligible due mainly to low CD4% but adherence to randomized treatment and retention in trial were excellent. A larger study to evaluate when to start ART is feasible.

References

  1. MMWR Recomm Rep. 1998 Apr 17;47(RR-4):1-43 - PubMed
  2. N Engl J Med. 1999 Aug 5;341(6):385-93 - PubMed
  3. J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):488-94 - PubMed
  4. AIDS. 2004 Sep 24;18(14):1915-24 - PubMed
  5. J Med Assoc Thai. 2002 Aug;85 Suppl 2:S690-3 - PubMed
  6. JAMA. 1998 Mar 11;279(10):756-61 - PubMed
  7. Arch Dis Child. 2001 Mar;84(3):230-6 - PubMed
  8. N Engl J Med. 1995 Aug 17;333(7):401-7 - PubMed
  9. BMC Infect Dis. 2006;6:10 - PubMed
  10. HIV Med. 2004 Jul;5 Suppl 2:61-86 - PubMed
  11. Cochrane Database Syst Rev. 2000;(2):CD002039 - PubMed
  12. Pediatrics. 2002 Aug;110(2 Pt 1):e25 - PubMed
  13. Pediatr Infect Dis J. 2006 Jun;25(6):533-7 - PubMed
  14. AIDS. 2004 Sep 3;18(13):1753-68 - PubMed
  15. JAMA. 2005 May 11;293(18):2213-20 - PubMed
  16. J Infect Dis. 1997 May;175(5):1029-38 - PubMed
  17. Lancet. 1994 Apr 9;343(8902):871-81 - PubMed
  18. AIDS. 2005 Mar 25;19(5):463-71 - PubMed
  19. Pediatr Infect Dis J. 2006 May;25(5):420-6 - PubMed
  20. Lancet. 2003 Nov 15;362(9396):1605-11 - PubMed

Publication Types